Enzyme Links Metabolic State to Inflammatory Response to Infection
July 25, 2016 An enzyme that stimulates the breakdown of fats in immune cells helps trigger inflammation, or an immune response to pathogens.
Awards and Honors Across Weill Cornell Medicine - Week of July 15 - July 22
July 22, 2016 Awards, honors, prizes and achievements for the week of July 15 - July 22.
Precision Cancer Test Validated for Clinical Usage
July 20, 2016 A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy.
Inflammatory Cells Implicated in Lung Disease in Severely Premature Infants
July 19, 2016 Inflammatory cells in the lungs of premature infants receiving oxygen contribute to the development of chronic lung problems.
We Are Weill Cornell Medicine: New Campaign Celebrates Accomplished, Collaborative Community
July 18, 2016 People are the heart and soul of Weill Cornell Medicine, driving our efforts to advance healthcare and biomedical science and inspiring us in our endeavors every day. A new multimedia campaign, called We Are Weill Cornell Medicine, celebrates the people who make the institution special.
Researchers Develop New Way to Target Tumors Using Nanotechnology
July 15, 2016 A protein in the blood vessels that feed tumors can be a more effective therapeutic target than the cancer cells themselves.
We Are Weill Cornell Medicine : Dr. Randy Longman
July 13, 2016 For gastroenterologist Dr. Randy Longman, having the greatest effect on his patients' lives means searching for new strategies to treat -- or even cure -- their disease.
Decisive Action Needed to Increase Patient Access to Hepatitis C Treatment
July 13, 2016 Despite the approval of effective hepatitis C virus (HCV) treatment regimens, the exceedingly high cost of the medication prevents it from reaching HCV patients.
Engineered Human Colon Model Could Aid in Cancer Research
July 11, 2016 A new tissue-engineering method enables researchers to track genetic changes driving cancer in humans.
NIH Awards Grant to Four New York City Medical Centers to Advance Precision Medicine
July 8, 2016 Researchers from Weill Cornell Medicine, Columbia University Medical Center, NewYork-Presbyterian and NYC Health + Hospitals/Harlem seek to extend the success of precision medicine in cancer to a broad range of diseases.

Calendar of Events